Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival
Open Access
- 10 January 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (2) , 239-246
- https://doi.org/10.1038/sj.bjc.6602920
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growthOncogene, 2004
- Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer ProgressionClinical Cancer Research, 2004
- Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cellsCancer Letters, 2004
- Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancerOncogene, 2003
- Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progressionEuropean Journal Of Cancer, 2003
- Reduced expression of transforming growth factor‐β receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2003
- Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinomaCancer, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.Genes & Development, 1996
- steroid receptor distribution in 47 892 breast cancers. A collaborative study of 7 European laboratoriesEuropean Journal Of Cancer, 1995